| NCT Number | NCT05946512 |
| Lead Sponsor | Medical University Innsbruck |
| Conditions | Post COVID-19 Condition, Somatic Symptom Disorder |
| Enrollment | 320 participants |
| Start Date | 2023-07-24 |
| Primary Completion | 2026-07-24 (estimated) |
| Study Completion | 2027-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2023-07-14 |